Report Finds Several Brand Name Drug Companies Waiting to Introduce New Products Until They Can Get Approval for More Lucrative Disease Classes It appears egregious price hikes on existing prescription drugs, out-of-control prices on new products and anti-competitive schemes to extend monopolies just aren’t enough to satisfy Big Pharma’s appetite for putting profits over patients. […]
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Maintain Monopoly Pricing Power and End-Run Solutions Meant to Discourage Price Increases Above the Rate of Inflation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on GSK’s strategy to discontinue the brand name inhaler Flovent and replace the product […]
Report Finds Big Pharma Increased Spending on R&D in First Half of 2023, Made R&D Investment Decisions Without Considering Impact of 2022 Drug Pricing Solutions A recent analysis from research firm ATI Advisory shows that in the first half of 2023, Big Pharma’s research and development (R&D) investment decisions were not impacted by drug pricing […]
Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Start the New Year Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on reports that brand name drug companies plan to hike prices on at least 500 prescription drugs to start the year, as part of the pharmaceutical industry’s traditional biennial […]
Big Pharma Discredited Its Own Bogus Rhetoric on Research and Development in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take a look […]
Big Pharma’s Tax Avoidance Schemes and Use of Kickbacks to Boost Profits Came Under Fire in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we […]
Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take a look back […]
Big Pharma’s Year of Big Spending Attempting to Evade Responsibility for High Prices and Advertise High-Priced Brand Name Products With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes […]
Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch Prices With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take […]
Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight Loss Products for Consumers and U.S. Health Care System During a hearing last Thursday in the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) titled, “What is Fueling the Diabetes Epidemic?,” expert witness Kasia Lipska, M.D., M.H.S, Associate Professor of Medicine at the Yale […]